The Factor II (Prothrombin) gene mutation analysis is a molecular genetic test used to detect specific mutations in the F2 gene, which encodes prothrombin (coagulation Factor II). The most clinically important variant is the G20210A mutation, which is associated with an increased risk of abnormal blood clot formation (thrombophilia).